Psychedelic music

Rising Prevalence of Mental Depression & Anxiety Major Drivers Propelling Demand In Psychedelic Drugs Market

Retrieved on: 
Wednesday, July 7, 2021
Hallucinations, Entheogens, Hallucinogen, Psychoactive drugs, Branches of biology, Dissociative, Psychedelic drug, Lysergic acid diethylamide, Drugs, Psychedelic music, Psychedelia

Psychedelic drugs can be categorized into empathogens and dissociative drugs (such as PCP) and serotonergic (classic hallucinogens) such as LSD.

Key Points: 
  • Psychedelic drugs can be categorized into empathogens and dissociative drugs (such as PCP) and serotonergic (classic hallucinogens) such as LSD.
  • According to Data Bridge Market Research, the psychedelic drugs market is expected to gain market growth in the forecast period of 2021 to 2028.
  • The rising prevalence of mental depression and anxiety and availability of off-label drugs are the major drivers which has propelled the demand of the psychedelic drugs market in the forecast period.The report said: "The awareness campaigns have encouraged people to select appropriate treatment for mental disorders procedures and professionals which is increasing the demand of psychedelic drugs and the rising awareness towards mental healthis acting as a driver for the psychedelic drugs market.
  • Increasing research and development expenditure in the psychedelic drugs is creating new opportunities in the psychedelic drugs market, thus increasing R&D activities in psychedelic drugs is acting as an opportunity for the growth of the psychedelic drugs market.

XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Latest Progress Report on Mescaline Program for Psychedelic Therapies

Retrieved on: 
Tuesday, June 15, 2021
Entheogens, Psychoactive drugs, Hallucinations, Cacti, Mescaline, Native American Church, Psychedelic drugs, Branches of biology, Psychedelic music, Psilocybin, GNU Multiple Precision Arithmetic Library, Software

The audio press release covers XPhytos recent announcement regarding the status of its GMP mescaline synthesis program.

Key Points: 
  • The audio press release covers XPhytos recent announcement regarding the status of its GMP mescaline synthesis program.
  • To hear the audio production, visit: https://www.nnw.fm/GFUhh
    To read the original press release, visit: https://www.nnw.fm/dcaCA
    "With both its North American GMP mescaline synthesis program and German-based psilocybin biotechnology production underway, the first stage of XPhyto's psychedelic medicine program is progressing on schedule.
  • As the manufacturing programs advance, we look forward to focusing our expertise on psychedelic drug formulation," said Hugh Rogers, CEO & Director.
  • IBN is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions.

May Psychedelic Capital Investigates Financial Media and Equality in the Boardroom

Retrieved on: 
Thursday, May 27, 2021
Psychedelic music

The next edition of the psychedelic investment series will be on Monday, May 31, 2021, at 1:30 PM EST.

Key Points: 
  • The next edition of the psychedelic investment series will be on Monday, May 31, 2021, at 1:30 PM EST.
  • The PsyCap May edition will feature engaging presentations from Psyched Wellness (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) Circadian Wellness Corp. , Nextage Therapeutics (TLV: NXTG)as well as panel discussions on the topic of Financial Media and Equality in the Boardroom.
  • Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space.
  • Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space.

Delic Holdings Inc. Confirms No Material Undisclosed Information and Comments on Recent Promotional Activities

Retrieved on: 
Saturday, May 8, 2021
Articles, Communication, Forward-looking statement, Psychedelic music, Public relations

The Company engaged IDR to provide financial marketing, public relations services, social media support and/or other related services.

Key Points: 
  • The Company engaged IDR to provide financial marketing, public relations services, social media support and/or other related services.
  • DELIC was the first psychedelic umbrella platform and is currently a trusted source for those interested in psychedelic culture, psychedelic clinics, and more.
  • In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, DELIC has made certain assumptions.
  • All subsequent written and oral forward- looking information and statements attributable to DELIC or persons acting on its behalf is expressly qualified in its entirety by this notice.\n'

NeonMind Developing Music Playlist for Psychedelic Therapy Sessions

Retrieved on: 
Tuesday, April 6, 2021
Hallucinations, Psychedelic music, Psychedelic drug

Vancouver, British Columbia--(Newsfile Corp. - April 6, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (FSE: 6UF) (OTC PINK: NMDBF) ("NeonMind"), is pleased to announce the commencement of a three phase university study dedicated to creating an ideal music playlist to accompany therapeutic psychedelic sessions.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - April 6, 2021) - NeonMind Biosciences Inc. (CSE: NEON) (FSE: 6UF) (OTC PINK: NMDBF) ("NeonMind"), is pleased to announce the commencement of a three phase university study dedicated to creating an ideal music playlist to accompany therapeutic psychedelic sessions.
  • Previous research has established that music for a therapeutic psychedelic session can significantly impact the experience.
  • To view an enhanced version of Figure 1, please visit:
    "The emotional arc of a musical playlist during a psychedelic session can play an important role in supporting someone's therapeutic experience," says Rob Tessarolo, President & CEO of NeonMind.
  • For more information on NeonMind, go to www.NeonMindBiosciences.com or buy NeonMind mushroom infused coffee at www.NeonMind.com .

March Psychedelic Capital Investigates Ethical IP and Financial Instruments

Retrieved on: 
Tuesday, March 30, 2021
Alternatives to animal testing, Clinical research, Microdosing, Pharmacokinetics, Psychedelic music

Toronto, Ontario--(Newsfile Corp. - March 30, 2021) - Microdose Psychedelic Insights ("Microdose"), the leader in B2B psychedelic intelligence, in partnership with The Conscious Fund , the most active VC fund in the psychedelic space, is pleased to present the next edition of Psychedelic Capital .

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - March 30, 2021) - Microdose Psychedelic Insights ("Microdose"), the leader in B2B psychedelic intelligence, in partnership with The Conscious Fund , the most active VC fund in the psychedelic space, is pleased to present the next edition of Psychedelic Capital .
  • (CSE: ENBI) (OTC Pink: ENTBF) (FSE: 1XU1), Mind Cure Health Inc (CSE: MCUR), NanoPsy, ATMA Journey Centres , Ethical IP and Financial Instruments panels are moderated by Zuber Lawler.
  • Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space.
  • Psychedelic Capital features the top companies, latest IPOs, newest opportunities and deepest insights into the emerging psychedelic space.

Delic Holdings, a Psychedelic Wellness-focused Company, Announces Appointment of John Coleman as Vice President of Business Development

Retrieved on: 
Tuesday, March 16, 2021
Subcultures, Psychedelia, Underground culture, OTC Markets Group, Delić, Psychedelic music, Surnames, Serbo-Croatian language

("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce the appointment of John Coleman, PhD, former President of Anandia Labs, as Vice President of Business Development.

Key Points: 
  • ("DELIC" or the "Company") (CSE: DELC) (OTCQB: DELCF), a psychedelic wellness-focused company, is pleased to announce the appointment of John Coleman, PhD, former President of Anandia Labs, as Vice President of Business Development.
  • Having John join as our VP of Business Development shows our commitment to bringing top tier professionals to our team and having leaders in each pillar of our growing business."
  • DELIC is positioning itself to be a leader in both the educational and scientific sides of the burgeoning psychedelic industry."
  • DELIC was the first psychedelic umbrella platform and is currently a trusted source for those interested in psychedelic culture, psychedelic clinics, and more.

Emerging Markets Report: A Psychedelic Story

Retrieved on: 
Tuesday, March 9, 2021
Articles, Psychiatry, Economy, Hallucinations, Economic geography, Emerging market, International development, Investment, Psychedelic drug, Mental disorder, Mental health, Psychedelic music

For the uninitiated, psychedelic companies have been enjoying increased interest in North American stock markets as research portends significant possible clinical use.

Key Points: 
  • For the uninitiated, psychedelic companies have been enjoying increased interest in North American stock markets as research portends significant possible clinical use.
  • A key reason is an intriguing trend within the mental health community: the evolving acceptance of psychedelic drugs for treating depression and other mental disorders.
  • Its a considerable footprint in the psychedelic market, especially with the seminal legalization efforts in Oregon in late 2020 .
  • About The Emerging Markets Report:
    The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience.

Patent Combining Psychedelics With Cannabinoids Allowed by USPTO

Retrieved on: 
Wednesday, February 10, 2021
Hallucinations, Cannabis, Psychoactive drugs, Canopy Growth, Hallucinogen, Effects of cannabis, Psychedelic drug, Psychedelic music, Mathematical optimization, Branches of biology

"With hundreds of applications still to prosecute, this is a great start."

Key Points: 
  • "With hundreds of applications still to prosecute, this is a great start."
  • More recently, Dr. Chadeayne built ebbu's intellectual property portfolio, which was pivotal in the startup company's success leading to an acquisition by cannabis giant, Canopy Growth Corporation.
  • CaaMTech is the foremost drug discovery and lead optimization company focused on engineering psychedelic drugs that meet the standards of modern medicine.
  • CaaMTech is improving the health and happiness of humankind by creating and optimizing psychedelic compounds and formulations through rigorous science and continuous innovation.

CFN Enterprises Inc. Adds Leading Psychedelic Wellness Brand to Client Roster

Retrieved on: 
Monday, January 25, 2021
CFN, Psychedelic music

Whitefish, Montana--(Newsfile Corp. - January 25, 2021) - CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced the addition of Delic Corp. (CSE: DELC) (OTCQB: DELCF), a leading psychedelic-wellness focused brand, to its client roster.

Key Points: 
  • Whitefish, Montana--(Newsfile Corp. - January 25, 2021) - CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced the addition of Delic Corp. (CSE: DELC) (OTCQB: DELCF), a leading psychedelic-wellness focused brand, to its client roster.
  • "We are excited to be working with a true pioneer in building psychedelic communities globally," said CFN Media President Frank Lane.
  • I look forward to seeing what we can do in the psychedelic space through our partnership with DELIC and CFN."
  • Delic was the first psychedelic umbrella media platform and is currently a trusted source for those interested in psychedelic science.